OptiNose Inc. OPTN) on Wednesday reported a loss of $360,000 in its fourth quarter.

Reports Q4 revenue $22.418M, consensus $20.82M.Light Up your Portfolio with Spark:Easily identify stocks' risks and opportunities. Discover ...

Company reports fourth quarter and full year 2024 XHANCE net revenue of $22.4 million and $78.2 million, increases of 13% and 10% compared to ...

OptiNose (OPTN) delivered earnings and revenue surprises of 95.71% and 5.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

YARDLEY, Pa. (AP) — YARDLEY, Pa. (AP) — OptiNose Inc. (OPTN) on Wednesday reported a loss of $360,000 in its fourth quarter. The Yardley, Pennsylvania-based company said it had a loss of 3 ...

March 26, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial ...

(RTTNews) - OptiNose Inc. (OPTN) revealed Loss for fourth quarter that decreased from last year and beat the Street estimates. The company's bottom line came in at -$0.36 million, or -$0.03 per share.

(RTTNews) - OptiNose, Inc. (OPTN), a pharmaceutical company, on Wednesday that its net loss narrowed in the fourth quarter compared with the last year. In the fourth quarter, net loss $0.36 ...